Desentum
Develops investigational allergen immunotherapies for people with pollen, food and animal allergies
Highlights
- New on EvolcAdded 2026-10-28
About Desentum
Desentum is a clinical-stage biopharmaceutical company developing allergen immunotherapies using modified recombinant allergens. Its lead candidate, DM-101PX, targets birch pollen allergy; candidates for peanut, grass pollen and cat allergies are in preclinical development.
The treatments are intended for people with allergies and aim to induce tolerance to specific allergens. The products are investigational and are not approved for marketing in any region.
Desentum was founded in 2011 as a spin-off from VTT Technical Research Centre of Finland and is headquartered in Espoo. It has received funding from Business Finland, the European Innovation Council and private investors.
Product: Investigational allergen immunotherapies based on modified recombinant allergens, including the birch pollen candidate DM-101PX.
Jobs at Desentum
Leadership
- Pekka Mattila · CEO, DesentumSource: company website
More biotech & pharma companies
EstiMates
Statistical, data management and bioinformatics services for clinical trials and life science research sponsorsNew on EvolcFaron Pharmaceuticals
Clinical-stage biopharma developing immunotherapies for cancer patients, led by bexmarilimab, an anti-Clever-1 antibodyNew on EvolcFinncure
Synthetic carrier particles for targeted drug delivery, developed for pharma and biotech partners in FinlandNew on EvolcFinVector
CGMP manufacturer of viral-based gene therapy products in Kuopio, Finland, for pharmaceutical partnersNew on EvolcGalena Pharma
Contract manufacturer of CE-marked medical devices and OTC health products sold as white-label for pharma and healthcare companiesNew on EvolcGencyst
Supplies antibodies, ELISA kits and lab reagents to research labs and runs bioequivalence studies for pharma developersYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- CookieYes
- Google Analytics 4
- Google reCAPTCHA
- WooCommerce
- WordPress
- jQuery
- nginx
